The dyslipidaemia is a state of abnormal levels of lipids (e.g. triglycerides, cholesterol and/or fat Phospholipids) in the plasma¹. It is characterised as hypercholesterolemia, low level of high density of

lipoproteins (HDL) and triglyceridemia.

Dyslipidemia is the major risk factor for the cardiovascular disease and is estimated to cause 2.6 million death and 29.7 million disability adjusted life year’s globally. According to the World Health Organisation, the prevalence of dyslipidemia in the south east Asia (30%), and the western pacific (36.7%) were much lower than that in Europe (53.7%) and the Americas (47.7%). However, the prevalence of it across the Asia pacific region varies.If dyslipidemia not monitored and left untreated, affects the overall health status of an individual which may lead to overall hardening of the arteries in the later years of life. Similarly atherosclerosis is a condition described in conventional medicine occurs due to excess deposition of lipids in vessels and finally it can lead to MI and sudden death .

Multiple epidemiologic studies have demonstrated a strong relationship between plasma levels of LDL-C and CHD. A direct connection between plasma cholesterol levels and the atherosclerotic process was made in humans.In modern system of medicine, the dyslipidemia is treated by following ways: Life style modification, exercise, diet, revascularisation and medication. Statins are the cornerstone of lipid lowering treatment. Several different types of statins with different pharmacological structures are now available as well as other lipids lowering drugs, plasma lipids levels, particularly those of LDL often are not optimally lowered to reach the recommended levels

Keeping this view, the adverse effects of statins, various experts of different fields are exploring the methods to control the effects of lipids abnormalities. In Unani System of Medicine various formulation has been indicated for the condition like dyslipidemia. The management is described under the caption of dasoomat-e-dam, therefore principle of treatment of dyslipidemia given on the same line of treatment of dasoomat-e-dam. The Unani formulation constitute following drugs which will be given in the form of powder: Badyan, Zeerakirmani, Bora armani, Suddab, Marzanjoshkhushk, Lukmaghsool, Nankhwah.